Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT03214562||Recruiting||Study of the BCL-2 Inhibitor Venetoclax in Combination With Standard Intensive Acute Myeloid Leukemia (AML) Induction/Consolidation Therapy With FLAG-IDA in Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia (AML)||
||Other / Industry||
||56||All||18 Years and older (Adult, Older Adult)||NCT03214562||2016-0979
710467 30 120634 28
|September 26, 2017||September 2023||September 2023||July 11, 2017||January 9, 2019||